Clinical Trial Update: Immune Therapies and Anti-HIV Therapy Withdrawal in Controlling Viral Load [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating immune therapies and withdrawal of anti-HIV therapy to control viral load in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED